Alan C Hayman, Deceased

Title: Alan C Hayman: Innovator in Cancer Treatment

Introduction

Alan C Hayman was a notable inventor whose work focused on the formulation and use of carotenoids in the treatment of cancer. His innovative approach aimed to create a reduced-toxicity formulation that could effectively combat cancer while minimizing adverse effects. Hayman's contributions to the field of cancer research have left a lasting impact.

Latest Patents

Hayman held a patent for a formulation that includes carotenoids, lipid carrier particles, and an intercalation promoter agent. This formulation is designed to be stable in an aqueous environment and allows for the carotenoid to be uniformly distributed within the lipid carrier particles. The molar ratio of carotenoid to lipid is greater than about 1:10. The patent also describes a method for inhibiting the growth of cancer cells by administering a therapeutically effective amount of the composition.

Career Highlights

Throughout his career, Hayman worked with esteemed organizations such as the University of Texas System and Aronex Pharmaceuticals, Inc. His work in these institutions contributed significantly to advancements in cancer treatment methodologies.

Collaborations

Hayman collaborated with notable colleagues, including Kapil Mehta and Roman Perez-Soler, who shared his vision for innovative cancer therapies.

Conclusion

Alan C Hayman's legacy as an inventor in the field of cancer treatment is marked by his innovative formulations and collaborative spirit. His work continues to inspire future research in the fight against cancer.